Skip to main content

Prostate Cancer Research Highlights

The American Cancer Society helps men with prostate cancer in every community. And we’re funding research to help find more cures and save even more lives in the future. 

Studies show that Black men are 2 times more likely to die from prostate cancer than White men are. A main cause could be disparities in the assessibility and delivery of quality care. 

Evidence keeps building that Black men are less likely to receive high-quality care for prostate cancer. When treatment is similar, prostate cancer 10-year survival is comparable or even higher among Black men.

Prostate Cancer Is #1 for 118 Countries Worldwide

Across the world, prostate cancer is second only to lung cancer as the most diagnosed cancer in men. For 66% of the world, prostate cancer is the #1 cancer in men.

world map with color coded countries by incidence of cancer types by country for men North and South America and Australia  are Purple

  

It is yet to be seen whether the 2018 updated USPSTF recommendations for informed decision-making for PSA-based screening for men ages 55 to 69 years will lead to an increase in PSA testing and halt or reverse the rise in late-stage prostate cancer-incidence rates.”

Ahmedin Jemal, DVM, PhD

Senior Vice President

Surveillance & Health Equity Science

close up portrait of Ahmedin Jemal, DVM, PhD, Scientific Vice President, Surveillance and Health Services Research ACS

Numbers to Know About Screening for Prostate Cancer 

50

age to start talking with doctor about prostate cancer for men who have an average risk 

45

age to start talking with doctor about prostate cancer for men with a family history and for Black men

40

age to start talking with doctor about prostate cancer for men who have more than 1 close relative with a history

Eye-Opening Prostate Cancer Statistics

70%

how much higher the prostate cancer incidence rate is for Black men compared to White men

100%

5-year survival rate for 83% of men diagnosed with localized prostate cancer

34%

5-year survival rate for men diagnosed with distant-stage prostate cancer

We Fund Cancer Researchers Across the US

The ACS funds scientists who conduct research about prostate cancer at medical schools, universities, research institutes, and hospitals throughout the United States. We use a rigorous and independent peer review process to select the most innovative research project proposals to fund. 

Stats below are as of July 15, 2024. 

42

prostate cancer grants

$37M

funding for prostate cancer